Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/06/2008WO2008132541A2 Conjugates of 2-fluoro-2-deoxy-glucose and their uses as anti cancer agents
11/06/2008WO2008132524A1 Novel apiary composition
11/06/2008WO2008132505A1 N' - (phenyl) -n- (morpholin-4-yl-pyridin-2-yl) -pyrimidine-2, 4-diamine derivatives as ephb4 kinase inhibitors for the treatment of proliferative conditions
11/06/2008WO2008132502A1 Pyrazolyl-amino-substituted pyrimidines and their use for the treatment of cancer
11/06/2008WO2008132458A1 Compositions useful in the modulation of immune responses and the treatment or prevention of inflammatory responses and related methods
11/06/2008WO2008132454A1 Carbolines and their use as imaging agents
11/06/2008WO2008132443A1 Use of sapacitabine to treat proliferative disease
11/06/2008WO2008132234A2 Rna antagonist compounds for the modulation of beta-catenin
11/06/2008WO2008132233A1 Composition, methods and kits for prevention of adhesion
11/06/2008WO2008132211A1 Amino-quinazolinone derivatives for use as radiotracers and imaging agents
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008132155A2 Inhibitors of the binding between hdm2 and the proteasome
11/06/2008WO2008132142A2 New heterocyclic derivatives useful for the treatment of cns disorders
11/06/2008WO2008132139A2 New heterocyclic derivatives useful for the treatment of cns disorders
11/06/2008WO2008132138A1 Derivatives of 4,6-disubstituted aminopyrimidines
11/06/2008WO2008132121A1 Lh-indazole-3-amine compounds as ikk1 inhibitors
11/06/2008WO2008132025A1 Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
11/06/2008WO2008131972A1 Arylmethylen substituted n-acyl-gamma-aminoalcohols
11/06/2008WO2008131961A1 Method for the production of adsorbates of a rasagiline salt having a water soluble adjuvant
11/06/2008WO2008131947A1 Substituted sulfonamide derivatives
11/06/2008WO2008131946A2 Substituted amide derivatives
11/06/2008WO2008131940A2 Combination of immunological agent and sensitizing agent for the treatment of cancer
11/06/2008WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008WO2008131921A1 Silylated, substituted benzotriazolylphenol compounds
11/06/2008WO2008131899A1 Preparation of polyfunctional fermented food products
11/06/2008WO2008131859A2 Use of cyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008WO2008131858A2 Use of acyclically substituted furopyrimidine derivatives for treating pulmonary arterial hypertonia
11/06/2008WO2008131807A2 Splice switching oligomers for tnf superfamily receptors and their use in treatment of disease
11/06/2008WO2008131779A1 Isoquinolinone derivatives as nk3 antagonists
11/06/2008WO2008131635A1 Acyclic nucleoside phosphonate derivatives and their medical use
11/06/2008WO2008131586A1 Uses of 5-methyl-1-(substituted phenyl)-2(1h)-pyridones as anti-inflammatory and tnf-alpha-blocking agents
11/06/2008WO2008131567A1 Solvent-free crystalline form of naltrexone
11/06/2008WO2008131552A1 Pseudopterosin-producing bacteria and methods of use
11/06/2008WO2008131547A1 'triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives'
11/06/2008WO2008131506A1 Mucoadhesive granules containing chitosan nano- and/or microspheres and the process of manufacture
11/06/2008WO2008131502A2 Antiviral compounds of the adamantane type
11/06/2008WO2008131491A1 Treatment of virally induced lesions
11/06/2008WO2008131481A1 Treatment of mesangioproliferative diseases
11/06/2008WO2008131469A2 Method for the production of highly pure 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions containing the same, and agent formulations containing tolperisone
11/06/2008WO2008116663A3 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
11/06/2008WO2008115863A3 Neuroprotection by psammaplysene a
11/06/2008WO2008113881B1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
11/06/2008WO2008113756A8 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
11/06/2008WO2008113483A3 Stabilization of vitamin b12
11/06/2008WO2008113149A3 Observations where certain claims were found unsearchable
11/06/2008WO2008112722A3 Imatinib mesylate
11/06/2008WO2008112498A3 Synthesis and characterization of polymorph form ii of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile
11/06/2008WO2008112218A3 Li-rnai involved li suppression in cancer immunotherapy
11/06/2008WO2008112129A3 Treatment of carcinomas with a combination of egf-pathway and telomerase inhibitors
11/06/2008WO2008109740A3 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
11/06/2008WO2008109719A3 Steroids derivatives as selective progesterone receptor modulators
11/06/2008WO2008109547A3 Nucleic acid compounds for inhibiting tymp gene expression and uses thereof
11/06/2008WO2008109526B1 Nucleic acid compounds for inhibiting egr gene expression and uses thereof
11/06/2008WO2008109518B1 Nucleic acid compounds for inhibiting wnt gene expression and uses thereof
11/06/2008WO2008109475B1 Nucleic acid compounds for inhibiting sirt2 gene expression and uses thereof
11/06/2008WO2008109364A3 Nucleic acid compounds for inhibiting frap1 gene expression and uses thereof
11/06/2008WO2008109361B1 Nucleic acid compounds for inhibiting erbb family gene expression and uses thereof
11/06/2008WO2008109354B1 Nucleic acid compounds for inhibiting il18 gene expression and uses thereof
11/06/2008WO2008106594A3 Inhibitors of nucleophosmin (npm) and methods for inducing apoptosis
11/06/2008WO2008106177A3 Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
11/06/2008WO2008106151A3 Co-crystals and pharmaceutical compositions comprising the same
11/06/2008WO2008104975A3 Combination therapy, composition and methods for the treatment of cardiovascular disorders
11/06/2008WO2008104473A3 Pyrazolopyriidine derivatives and their use as kinase inhibitors
11/06/2008WO2008102349A3 Terbinafine formulation for iontophoresis
11/06/2008WO2008100997A3 Methods for treating or preventing hemorrhagic cystitis using a glycerophosphate salt
11/06/2008WO2008100629A3 Glutathione peroxidase mimetics for the treatment of dermatoses
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008099068A3 Liquid anhydrous composition to be incorporated into the drinking water of cattle
11/06/2008WO2008096081A3 Use of riluzole and derivatives thereof for producing new drugs
11/06/2008WO2008095086A3 Topiramate plus naltrexone for the treatment of addictive disorders
11/06/2008WO2008094976A3 Use of estrogen receptor beta selective ligands for treating acute lung injuries
11/06/2008WO2008091704A3 Treatment of cushing's syndrome and autism
11/06/2008WO2008091692A3 Methods of diagnosing, treating, and preventing increased vascular permeability
11/06/2008WO2008090565B1 Novel thermodynamically stable polymorphic form-l of letrozole
11/06/2008WO2008089307A3 Delta 5 desaturase inhibitors for the treatment of pain, inflammation and cancer
11/06/2008WO2008089103A3 Targeting ncca-atp channel for organ protection following ischemic episode
11/06/2008WO2008087367A3 Substituted (phenylthiazolyl)-phenyl-propan-1-one and (phenyloxazodyl)-phenyl-propan-1-one derivatives, preparations and uses of same
11/06/2008WO2008087348A3 Emulsion comprising at least one retinoid and benzoyl peroxide
11/06/2008WO2008086176A3 Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease
11/06/2008WO2008086006A3 Sp35 antibodies and uses thereof
11/06/2008WO2008084312A3 Micronised particles of low-dosage strength active agents for powder formulations for inhalation
11/06/2008WO2008082692A3 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
11/06/2008WO2008079291A3 Substituted heterocycles and methods of use
11/06/2008WO2008079266A3 Synthesis of pyrrolidine compounds
11/06/2008WO2008078196A3 Substituted heteroaryl pyridopyrimidone derivatives
11/06/2008WO2008076370A3 P21 compositions and methods for the treatment of hiv
11/06/2008WO2008076046A8 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
11/06/2008WO2008075155A3 Carbonic anhydrase inhibitors derivatives
11/06/2008WO2008072190A3 Compositions of azimilide dihydrochloride
11/06/2008WO2008072053A3 Substituted arylpyrazoles
11/06/2008WO2008070358A3 N-cyclopropyl-hydroxyproline-based tripeptidic hepatitis c serine protease inhibitors containing an isoindole, pyrrolopyridine, pyrrolopyrimidine or pyrrolopyrazine heterocycle in the side chain
11/06/2008WO2008070230A3 Methods and compositions for treating central nervos system tumors
11/06/2008WO2008070169A3 Use of carboxyamidotriazole (cai) orotate in macular degeneration
11/06/2008WO2008068593A3 Motilide polymorphs
11/06/2008WO2008067305A3 Polypeptides comprising intracytoplasmic death domain and nkg2d ligand domain
11/06/2008WO2008067086A3 Compositions and methods for suppressing endometrial proliferation
11/06/2008WO2008067037A3 Novel formulations of proton pump inhibitors and methods of using these formulations
11/06/2008WO2008067002A3 Azole nucleosides and use as inhibitors of rna and dna varial polymerases
11/06/2008WO2008065316A3 Ointment compositions comprising a vitamin d derivative
11/06/2008WO2008063806A3 Medical device coatings and coated stents
1 ... 3006 3007 3008 3009 3010 3011 3012 3013 3014 3015 3016 3017 3018 3019 3020 3021 3022 3023 3024 3025 3026 ... 7860